National Health Investors, Inc. (NYSE:NHI) Short Interest Down 29.8% in December

National Health Investors, Inc. (NYSE:NHI) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling 1,387,280 shares, a drop of 29.8% from the December 15th total of 1,975,807 shares. Based on an average trading volume of 230,633 shares, the short-interest ratio is currently 6.0 days. Approximately 3.2% of the shares of the stock are short sold. Approximately 3.2% of the shares of the stock are short sold. Based on an average trading volume of 230,633 shares, the short-interest ratio is currently 6.0 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its stake in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares during the period. GAMMA Investing LLC raised its holdings in National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 136 shares in the last quarter. Assetmark Inc. lifted its position in National Health Investors by 19.0% during the second quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock valued at $65,000 after buying an additional 148 shares during the period. Advisory Services Network LLC bought a new stake in shares of National Health Investors during the 3rd quarter valued at $65,000. Finally, Triumph Capital Management purchased a new stake in shares of National Health Investors in the 3rd quarter worth about $66,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Trading Down 0.4%

NHI traded down $0.34 during midday trading on Monday, reaching $80.09. 260,061 shares of the company’s stock traded hands, compared to its average volume of 163,318. The firm has a fifty day moving average of $77.86 and a two-hundred day moving average of $76.10. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 25.26, a P/E/G ratio of 2.99 and a beta of 0.67. The company has a debt-to-equity ratio of 0.74, a current ratio of 10.64 and a quick ratio of 10.64. National Health Investors has a 52 week low of $65.22 and a 52 week high of $80.87.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.08. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The firm had revenue of $83.36 million for the quarter, compared to analyst estimates of $85.66 million. During the same period last year, the company earned $1.03 EPS. The business’s quarterly revenue was down 1.8% compared to the same quarter last year. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, equities analysts anticipate that National Health Investors will post 4.41 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio is presently 116.09%.

Analysts Set New Price Targets

Several equities analysts recently commented on NHI shares. Truist Financial increased their target price on shares of National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a report on Monday, December 15th. KeyCorp boosted their target price on National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Cantor Fitzgerald set a $85.00 price target on National Health Investors in a research report on Monday, January 5th. Wells Fargo & Company lifted their price target on National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th. Finally, National Bankshares set a $90.00 price objective on National Health Investors in a research note on Wednesday, October 1st. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $86.50.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.